Diagnosis of metachronous recurrence after endoscopic submucosal dissection for gastric neoplasia using autofluorescence imaging

Diagnosis of metachronous recurrence after endoscopic submucosal dissection for gastric neoplasia using autofluorescence imaging - Diagnosis of metachronous recurrence after ESD for gastric neoplasia using AFI

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000003120

Enrollment

200

Registered

2010-01-31

Start date

2010-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

early gastric cancer or gastric adenoma

Interventions

WLE WLE and AFI

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients after ESD for early gastric cancer or gatric adenoma

Exclusion criteria

Exclusion criteria: after gastrectomy

Design outcomes

Primary

Measure	Time frame
detection rate of metachronous lesions	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026